Hend A. A. Ezelarab

New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization

Hend A. A. Ezelarab, Taha F. S. Ali, Samar H. Abbas et al. · Molecular Diversity · 2023 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Novel 3,4-diaminothieno[2,3-b]thiophene-2,5-dicarbohydrazide-based scaffolds as EGFRWT, EGFRT790M, and tubulin polymerization inhibitors with anti-proliferative activity

Moustafa O. Aboelez, Mahmoud Abd El Aleem Ali Ali El‐Remaily, Moumen S. Kamel et al. · Bioorganic Chemistry · 2025 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFR^WT and EGFR^T790M: integrating biological, molecular docking, and ADMET analysis

Hany M. Abd El‐Lateef, Hend A. A. Ezelarab, Ali M. Ali et al. · RSC Advances · 2024 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Guanidine dicycloamine-based analogs: green chemistry synthesis, biological investigation, and molecular docking studies as promising antibacterial and antiglycation leads

Mahmoud A. E. A. A. A. El-Remaily, Moustafa O. Aboelez, Hend A. A. Ezelarab et al. · Molecular Diversity · 2024 · 20 citations

Pharmacy, Chemistry, Medicinal Chemistry +16

Design, synthesis, and biological investigation of quinoline/ciprofloxacin hybrids as antimicrobial and anti-proliferative agents

Hend A. A. Ezelarab, Heba A. Hassan, Gamal El‐Din A. Abuo‐Rahma et al. · Journal of the Iranian Chemical Society · 2022 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14